Extended Data Fig. 1: CONSORT diagrams for TRACERx 100 and LATTICe-A histology cohorts and patient characteristics. | Nature Medicine

Extended Data Fig. 1: CONSORT diagrams for TRACERx 100 and LATTICe-A histology cohorts and patient characteristics.

From: Geospatial immune variability illuminates differential evolution of lung adenocarcinoma

Extended Data Fig. 1

a. TRACERx CONSORT diagram to illustrate sample collection and analysis of regional and diagnostic histology samples, as well as the overlap with RNA-seq and DNA-seq studies. b. TRACERx patient characteristics for the histology cohort. c. LATTICe-A CONSORT diagram (n = 970 LUAD patients). Legends for ‘type of the analysis’ correspond to panel a. d. Demographics and clinical patient characteristics for TRACERx (top three panels) and LATTICe-A (bottom three panels) showing the distribution of age (colored by sex), distribution of smoking pack years and the proportion of patients in each pathological stage. Horizontal lines indicate the median value.

Back to article page